All News

2020

October

Media Release / Oct 06, 2020

Sandoz Zarxio® demonstrates cost-effectiveness for breast cancer patients at intermediate risk when used as primary prophylaxis to decrease the incidence of febrile neutropenia following first-round of chemotherapy

Read More
Media Release / Oct 01, 2020

Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals

Read More

August

Media Release / Aug 10, 2020

Sandoz launches Ciprofloxacin + Dexamethasone otic suspension in US for treatment of middle and outer ear bacterial infections

Read More

July

Media Release / Jul 13, 2020

Sandoz launches generic antibiotic Daptomycin in US, strategically growing injectables portfolio and strengthening hospital offering

Read More
Media Release / Jul 07, 2020

Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals

Read More
Media Release / Jul 01, 2020

Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case

Read More

June

Media Release / Jun 15, 2020

Novartis manufactures and donates 27,000 units of hand sanitizer to New York State

Read More

May

Media Release / May 13, 2020

Sandoz Glatopa® demonstrates trend towards lower relapse rates and costs for MS patients in US compared to originator medicine in real-world study

Read More

April

Media Release / Apr 02, 2020

Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo

Read More

March

Media Release / Mar 30, 2020

Novartis donates 20,000 doses of hydroxychloroquine for COVID-19 PEP clinical trial

Read More